ACN
50
-6
NEM
41
9
INTC
37
2
CHD
32
-2
LH
33
-2
R
59
4
SYY
41
-2
RRC
58
6
PHM
46
2
GOOGL
64
2
JNJ
35
5
GWW
48
-2
HUM
29
4
CNP
52
-7
SNA
56
-2
BF.B
33
-3
PM
47
-2
FFIV
63
2
HP
34
-10
HSIC
44
2
ACN
50
-6
NEM
41
9
INTC
37
2
CHD
32
-2
LH
33
-2
R
59
4
SYY
41
-2
RRC
58
6
PHM
46
2
GOOGL
64
2
JNJ
35
5
GWW
48
-2
HUM
29
4
CNP
52
-7
SNA
56
-2
BF.B
33
-3
PM
47
-2
FFIV
63
2
HP
34
-10
HSIC
44
2
Financhill
Back

Cellectar Biosciences 10K Form

Sell
40

CLRB
Cellectar Biosciences

Last Price:
$0.26
Seasonality Move:
-2.17%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CLRB News And Ratings

See the #1 stock for the next 7 days that we like better than CLRB

CLRB Financial Statistics

Sales & Book Value

Annual Sales: $0
Cash Flow: $-9.2M
Price / Cash Flow: 0
Annual Sales: $0.04
Price / Book: 7.34

Profitability

EPS (TTM): -1.90000
Net Income (TTM): $-50.1M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

Cellectar Biosciences Earnings Forecast

Key Cellectar Biosciences Financial Ratios

  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 19 years have been positive in 15 years.

Cellectar Biosciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: CLRB
CUSIP: 15117F
Website: cellectar.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

CLRB Technical Analysis vs Fundamental Analysis

Sell
40
Cellectar Biosciences (CLRB) is a Sell

Is Cellectar Biosciences a Buy or a Sell?